Drug profile · INN
kn046
kn046 is a cytotoxic t-lymphocyte protein 4 inhibitor.
NMPA: clinical trials
Patents linked 0
Pipeline programs 3
News articles 1
Drug details — kn046
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.70
Quick answer
kn046 is a cytotoxic t-lymphocyte protein 4 inhibitor.
Key facts
INN kn046
Mechanism Cytotoxic T-lymphocyte protein 4 inhibitor
Target Cytotoxic T-lymphocyte protein 4
Mechanism of action
Cytotoxic T-lymphocyte protein 4 inhibitor
Primary target: Cytotoxic T-lymphocyte protein 4
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is kn046?
kn046 is a cytotoxic t-lymphocyte protein 4 inhibitor.